Basic Fibroblast Growth Factor Inhibits Gonadotropin Supported Ovarian Androgen Biosynthesis: Mechanism(s) and Site(s) of Action*
- 1 June 1990
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 126 (6) , 3089-3095
- https://doi.org/10.1210/endo-126-6-3089
Abstract
Current evidence favors the hypothesis that granulosa cell-derived basic fibroblast growth factor (bFGF) may be the centerpiece of an intraovarian autocrine loop. In this report we examine the possibility that bFGF may also be involved in paracrine interactions at the level of the ovarian theca-interstitial cell. To this end, whole ovarian dispersates obtained from immature rats were cultured for 96 h under serum-free conditions. The accumulation of androsterone, the major androgenic steroid detected, increased 3- to 5-fold over baseline in response to treatment with hCG (1 ng/ml) an effect further optimized (20 to 40-fold) by supplementation with insulin-like growth factor-I (10 ng/ml), insulin (1 .mu.g/ml), terbutaline (10-6 M), or high density lipoprotein (100 .mu.g/ml). In the absence of these optimizing supplements, bFGF was without effect on basal androsterone accumulation, but produced a relatively modest (20%) inhibition of hCG hormonal action. In contrast, bFGF proved a highly potent inhibitor (80%) of hCG-stimulated androgen biosynthesis in supplement-enriched cultures. This reversible bFGF action proved to be time and dose dependent, with a minimal time requirement of 48 h and a median inhibitor dose of 2 ng/ml. Unaccounted for by altered (hCG-stimulated) cAMP generation or a diminution in the viable cell mass, the antigonadotropic effect of bFGF may be inference be assumed to involve a site(s) of action distal to or independent of cAMP generation. In this connection, cellular radiolabeling with [3H]pregnanolone (3.alpha.-hydroxy-5.alpha.-pregnane-20-one) revealed bFGF to be a potent inhibitor of the steroidogenic enzyme 17.alpha.-hydroxylase/17-20-lyase. As such, these findings are in keeping with the possibility that locally derived bFGF may exert a dual inhibitory action on (mature) ovarian estrogen production by reducing androgen substrate provision as well as by exercising its now established ability to attenuate granulosa cell aromatase activity.This publication has 20 references indexed in Scilit:
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factorPublished by Elsevier ,2004
- Basic and acidic fibroblast growth factors interact with the same cell surface receptors.Journal of Biological Chemistry, 1986
- Isolation of novel microbial 3 alpha-, 3 beta-, and 17 beta-hydroxysteroid dehydrogenases. Purification, characterization, and analytical applications of a 17 beta-hydroxysteroid dehydrogenase from an Alcaligenes sp.Journal of Biological Chemistry, 1985
- Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.Proceedings of the National Academy of Sciences, 1985
- Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition.Proceedings of the National Academy of Sciences, 1985
- Epidermal growth factor antagonizes ovarian theca-interstitial cytodifferentiationMolecular and Cellular Endocrinology, 1983
- Primary culture of differentiating ovarian androgen-producing cells in defined medium.Journal of Biological Chemistry, 1982
- Growth Factors Modulate Gonadotropin Receptor Induction in Granulosa Cell CulturesScience, 1981
- The Effects of the Epidermal and Fibroblast Growth Factors on the Replicative Lifespan of Cultured Bovine Granulosa Cells*Endocrinology, 1978
- Effects of Fibroblast and Epidermal Growth Factors on Ovarian Cell Proliferationin Vitro. I. Characterization of the Response of Granulosa Cells to FGF and EGFEndocrinology, 1977